News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
764,889 Results
Type
Article (45812)
Company Profile (349)
Press Release (718713)
Multimedia
Podcasts (181)
Webinars (31)
Section
Business (244530)
Career Advice (2106)
Deals (36910)
Drug Delivery (151)
Drug Development (84936)
Employer Resources (176)
FDA (17076)
Job Trends (15568)
News (361022)
Policy (33816)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (7)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (6)
Academia (2786)
Accelerated approval (60)
ADA (49)
Adcomms (36)
Allergies (203)
Alliances (53324)
ALS (239)
Alzheimer's disease (1978)
Antibody-drug conjugate (ADC) (575)
Approvals (17522)
Artificial intelligence (815)
ASCO (337)
Autoimmune disease (372)
Automation (69)
Bankruptcy (377)
Best Places to Work (12083)
BIO (76)
BIOSECURE Act (21)
Biosimilars (252)
Biotechnology (246)
Bladder cancer (213)
Brain cancer (81)
Breast cancer (837)
Cancer (6638)
Cardiovascular disease (544)
Career advice (1790)
Career pathing (48)
CAR-T (379)
CDC (64)
Celiac Disease (3)
Cell therapy (1045)
Cervical cancer (56)
Clinical research (74125)
Collaboration (2449)
Commercialization (1)
Company closure (5)
Compensation (1574)
Complete response letters (103)
COVID-19 (2873)
CRISPR (127)
C-suite (1348)
Cystic fibrosis (169)
Data (8938)
Decentralized trials (3)
Denatured (72)
Depression (195)
Dermatology (105)
Diabetes (690)
Diagnostics (7262)
Digital health (67)
Diversity (14)
Diversity, equity & inclusion (46)
Drug discovery (414)
Drug pricing (221)
Drug shortages (32)
Duchenne muscular dystrophy (333)
Earnings (94168)
Editorial (76)
Employer branding (21)
Employer resources (159)
Events (126795)
Executive appointments (1202)
FDA (21266)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (37)
Funding (1988)
Gene editing (275)
Generative AI (72)
Gene therapy (840)
GLP-1 (1180)
Government (4976)
Grass and pollen (6)
Guidances (423)
Healthcare (19960)
Hematology (196)
HIV (94)
Huntington's disease (68)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (119)
Immunology and inflammation (353)
Immuno-oncology (118)
Indications (227)
Infectious disease (3261)
Inflammatory bowel disease (238)
Inflation Reduction Act (17)
Influenza (152)
Intellectual property (329)
Interviews (333)
IPO (17147)
IRA (54)
Job creations (3794)
Job search strategy (1478)
JPM (68)
Kidney cancer (22)
Labor market (114)
Layoffs (631)
Leadership (45)
Legal (8159)
Liver cancer (108)
Longevity (36)
Lung cancer (881)
Lymphoma (490)
Machine learning (67)
Management (62)
Manufacturing (1239)
Marketing (7)
MASH (224)
Medical affairs (1)
Medical device (14406)
Medtech (14592)
Mergers & acquisitions (21108)
Metabolic disorders (1762)
mRNA (269)
Multiple sclerosis (208)
NASH (21)
Neurodegenerative disease (518)
Neuropsychiatric disorders (124)
Neuroscience (3741)
Neurotech (1)
NextGen: Class of 2026 (7031)
Non-profit (4796)
Now hiring (83)
Obesity (826)
Opinion (338)
Ovarian cancer (249)
Pain (281)
Pancreatic cancer (368)
Parkinson's disease (423)
Partnered (42)
Patents (666)
Patient recruitment (819)
Peanut (70)
People (62598)
Pharmaceutical (60)
Pharmacy benefit managers (35)
Phase 1 (23299)
Phase 2 (32684)
Phase 3 (24176)
Pipeline (10314)
Policy (364)
Postmarket research (2616)
Preclinical (9954)
Press Release (70)
Prostate cancer (350)
Psychedelics (71)
Radiopharmaceuticals (374)
Rare diseases (1303)
Real estate (6265)
Recruiting (73)
Regulatory (26852)
Reports (57)
Research institute (2605)
Resumes & cover letters (365)
Rett syndrome (46)
RNA editing (31)
RSV (94)
Schizophrenia (197)
Series A (345)
Series B (250)
Service/supplier (7)
Sickle cell disease (132)
Special edition (30)
Spinal muscular atrophy (175)
Sponsored (51)
Startups (3969)
State (2)
Stomach cancer (20)
Supply chain (142)
Tariffs (92)
The Weekly (106)
Vaccines (1230)
Venture capital (140)
Weight loss (536)
Women's health (144)
Worklife (22)
Date
Today (102)
Last 7 days (457)
Last 30 days (2041)
Last 365 days (31776)
2026 (17649)
2025 (31486)
2024 (36561)
2023 (41477)
2022 (52778)
2021 (57294)
2020 (55758)
2019 (48626)
2018 (36672)
2017 (33658)
2016 (33085)
2015 (39207)
2014 (32824)
2013 (27726)
2012 (29749)
2011 (30431)
2010 (28470)
Location
Africa (797)
Alabama (101)
Alaska (7)
Arizona (382)
Arkansas (16)
Asia (42736)
Australia (7083)
California (14490)
Canada (4067)
China (1611)
Colorado (623)
Connecticut (636)
Delaware (442)
Europe (94881)
Florida (2178)
Georgia (462)
Hawaii (3)
Idaho (68)
Illinois (1208)
India (106)
Indiana (651)
Iowa (25)
Japan (623)
Kansas (138)
Kentucky (55)
Louisiana (59)
Maine (91)
Maryland (1711)
Massachusetts (10505)
Michigan (382)
Minnesota (784)
Mississippi (7)
Missouri (157)
Montana (36)
Nebraska (30)
Nevada (156)
New Hampshire (90)
New Jersey (3790)
New Mexico (34)
New York (3803)
North Carolina (1898)
North Dakota (11)
Northern California (7303)
Ohio (438)
Oklahoma (27)
Oregon (43)
Pennsylvania (2857)
Puerto Rico (32)
Rhode Island (52)
South America (1160)
South Carolina (91)
South Dakota (2)
Southern California (5744)
Tennessee (238)
Texas (2347)
United States (51340)
Utah (430)
Vermont (2)
Virginia (357)
Washington D.C. (83)
Washington State (1179)
West Virginia (4)
Wisconsin (140)
Wyoming (2)
764,889 Results for "partner therapeutics inc ptx".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Artificial intelligence
Secretive AI drug hunter Xaira dips toe into dealmaking with hunt for partners
A mostly black box since emerging with more than a billion dollars in hand, Xaira Therapeutics is slowly pulling back the curtain, revealing plans to find partners and validate its pipeline.
July 8, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Avalo Therapeutics to Participate in the Leerink Partners Therapeutics Forum
July 7, 2026
·
1 min read
Approvals
Partner’s Bizengri cleared by FDA for ultra-rare cancer days after winning priority voucher
Partner Therapeutics announced last week that the FDA had granted Bizengri a Commissioner’s National Priority Voucher to accelerate drug review.
May 11, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Polaroid Therapeutics (PTx) Receives CE Mark for POLTX_Fiber™: the first application of APT™ to launch a new standard in wound care
February 25, 2026
·
4 min read
Press Releases
Partner Therapeutics Announces Publication of Results From the eNRGy Trial of Zenocutuzumab in Patients with NRG1+ Cholangiocarcinoma in Journal of Clinical Oncology (JCO)
July 2, 2026
·
12 min read
Press Releases
Palisade Bio to Participate in the Leerink Partners Therapeutics Forum
July 13, 2026
·
3 min read
Press Releases
Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger
July 2, 2026
·
6 min read
Press Releases
Partner Therapeutics Announces Receipt of FDA Commissioner’s National Priority Voucher for BIZENGRI® (Zenocutuzumab-zbco) in NRG1 Fusion-Positive Cholangiocarcinoma
May 6, 2026
·
11 min read
Press Releases
Partner Therapeutics announces submission of supplemental Biologics License Application (sBLA) to FDA for BIZENGRI® (zenocutuzumab-zbco) in NRG1 Fusion Positive Cholangiocarcinoma and Inclusion in updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
April 15, 2026
·
9 min read
Immuno-oncology
ASCO: Akeso’s VEGF/PD-1 boosts lung cancer survival, relieving pressure on US partner Summit
Analysts, investors and partner Summit Therapeutics had all been keenly awaiting the overall survival update, after previous data from Akeso’s HARMONi-6 trial left them wanting.
May 31, 2026
·
3 min read
·
Annalee Armstrong
1 of 76,489
Next
